Genetic testing is the linchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 175,000 unique genetic testing products on the market, and an average of 10-15 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed.
Founded in 2010 with a vision to simplify this complexity, Concert (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans.
With a leading team of clinicians, researchers, data scientists and software engineers, Concert launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization.
Today, stakeholders across the healthcare system turn to Concert to better understand and navigate the rapid transformation to precision medicine that is underway.
See Our Solutions